Patent details

Basic Information

Publication number:

EP2307007

PCT Application Number:

PCT/EP/2009/059440

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097809388

PCT Publication Number:

WO/2010/010127

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION

French Title of Invention:

MODULATEURS DU RÉCEPTEUR DE SPHINGOSINE 1 PHOSPHATE ET LEUR UTILISATION POUR LE TRAITEMENT DE L'INFLAMMATION MUSCULAIRE

German Title of Invention:

SPHINGOSIN-1-PHOSPHATREZEPTORMODULATOREN UND IHRE VERWENDUNG ZUR BEHANDLUNG VON MUSKELENTZÜNDUNGEN

SPC Number:

Dates

Filing date:

22/07/2009

Grant date:

27/08/2014

EP Publication Date:

27/08/2014

PCT Publication Date:

28/01/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/04/2011

EP B1 Publication Date:

27/08/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/07/2016

Expiration date:

22/07/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/07/2009

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

GERGELY Peter

Address:

Switzerland (CH)

2

Name:

AHMED Syed Sohail

Address:

Italy (IT)

3

Name:

LONDEI Marco

Address:

United States (US)

4

Name:

WRIGHT Timothy

Address:

United States (US)

Priority

Priority Number:

08161005

Priority Date:

23/07/2008

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/397;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/07/2015

Last Annual Fee Paid Number:

7

Last Annual Fee Paid Amount:

82 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages